home / stock / mthry / mthry quote
Last: | $5.75 |
---|---|
Change Percent: | 4.2% |
Open: | $5.7 |
Close: | $5.75 |
High: | $5.8699 |
Low: | $5.63 |
Volume: | 64,888 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$5.75 | $5.7 | $5.75 | $5.8699 | $5.63 | 64,888 | 04-26-2024 |
$5.95 | $6.03 | $5.95 | $6.03 | $5.93 | 100,439 | 04-25-2024 |
$6.0699 | $6.088 | $6.0699 | $6.088 | $6.03 | 184,664 | 04-24-2024 |
$6.13 | $6.04 | $6.13 | $6.14 | $5.91 | 375,261 | 04-23-2024 |
$6 | $5.98 | $6 | $6.16 | $5.97 | 409,716 | 04-22-2024 |
$5.76 | $5.84 | $5.76 | $5.94 | $5.76 | 162,963 | 04-19-2024 |
$6.0235 | $6.04 | $6.0235 | $6.07 | $6 | 161,821 | 04-18-2024 |
$6.05 | $6.04 | $6.05 | $6.25 | $6.04 | 201,773 | 04-17-2024 |
$6.22 | $6.09 | $6.22 | $6.255 | $6.09 | 256,614 | 04-16-2024 |
$6.06 | $6.2975 | $6.06 | $6.2975 | $6.06 | 171,522 | 04-15-2024 |
$6.29 | $6.405 | $6.29 | $6.56 | $6.26 | 45,271 | 04-12-2024 |
$6.38 | $6.36 | $6.38 | $6.44 | $6.29 | 349,326 | 04-11-2024 |
$6.49 | $6.45 | $6.49 | $6.714 | $6.39 | 266,117 | 04-10-2024 |
$6.65 | $6.64 | $6.65 | $6.776 | $6.5814 | 203,942 | 04-09-2024 |
$6.76 | $6.7425 | $6.76 | $6.78 | $6.73 | 173,833 | 04-08-2024 |
$6.7 | $6.698 | $6.7 | $6.75 | $6.695 | 57,758 | 04-05-2024 |
$6.88 | $6.97 | $6.88 | $7.02 | $6.81 | 102,694 | 04-04-2024 |
$7 | $6.835 | $7 | $7 | $6.835 | 59,346 | 04-03-2024 |
$7.06 | $7.155 | $7.06 | $7.4099 | $7.04 | 39,395 | 04-02-2024 |
$7.15 | $7.14 | $7.15 | $7.16 | $7.1 | 43,972 | 04-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
M3 Company Name:
MTHRY Stock Symbol:
OTCMKTS Market:
M3 WAKE RESEARCH EXPANDS INTO CHARLESTON, SC PR Newswire New Partnership Adds Award-winning Clinical Research Leader, Dr. Donald Hurley , to Wake Research's National Network CHARLESTON, S.C. , July 7, 2023 /PRNewswire/ -- M3 Wake Research, a leadi...
M3 WAKE RESEARCH POISED TO EXPAND PHASE I TRIAL SERVICES PR Newswire New Executive Role Will Lead Growth of Phase I Trial Operations Beyond RTP RALEIGH, N.C. , March 7, 2023 /PRNewswire/ -- M3 Wake Research, a leading fully integrated network of clinical ...
M3-WAKE RESEARCH ACQUIRES MULTI-SPECIALTY RESEARCH ASSOCIATES OF LAKE CITY, FLORIDA PR Newswire Addition of Well-Established Clinical Research Site Expands Operations into Florida , Offers Multi-specialty Expertise including Vaccines, Primary Care, and Women's Heal...